Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insmed Inc INSM

Healthcare Biotechnology
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs... see more

Recent & Breaking News (NDAQ:INSM)

Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List

PR Newswire October 28, 2021

Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update

PR Newswire October 28, 2021

Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021

PR Newswire October 14, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire October 5, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire September 3, 2021

Insmed To Participate in Five September Conferences

PR Newswire September 1, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire August 6, 2021

Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update

PR Newswire August 5, 2021

Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021

PR Newswire July 27, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire July 8, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire June 4, 2021

Insmed To Present at Two June Conferences

PR Newswire May 25, 2021

Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference

PR Newswire May 19, 2021

Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes

PR Newswire May 13, 2021

Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028

PR Newswire May 11, 2021

Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028

PR Newswire May 10, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire May 7, 2021

Insmed Reports First Quarter 2021 Financial Results and Provides Business Update

PR Newswire May 6, 2021

Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021

PR Newswire April 22, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire April 7, 2021